Proteolysis Targeting Chimera
Posts Tagged ‘NF-κB’
Can Proteins be Modified to Fight Diseases and Cancer?
Posted by Michael A. S. Guth on January 4th, 2024
Posted in Regulatory Medical Writing 
Tags: Disease-Causing Proteins, monoclonal antibodies (mAbs), NF-κB, PROTAC, Proteolysis Targeting Chimera, Proteolysis Targeting Chimerics, small molecule inhibitors (SMIs), transcription factors, Ubiquitin-Proteasome System (UPS) 
Comments Off on Can Proteins be Modified to Fight Diseases and Cancer?